BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2921356)

  • 21. Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study.
    Boman F; Buisine MP; Wacrenier A; Querleu D; Aubert JP; Porchet N
    J Pathol; 2001 Mar; 193(3):339-44. PubMed ID: 11241413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.
    Curling M; Stenning S; Hudson CN; Watson JV
    J Clin Pathol; 1998 Jun; 51(6):455-61. PubMed ID: 9771445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Distribution and diagnostic role of COTA in mucinous ovarian tumors].
    Shi ZL
    Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):191-2. PubMed ID: 2612330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogene expression in ovarian cancer: a pilot study of c-myc oncoprotein in serous papillary ovarian cancer.
    Watson JV; Curling OM; Munn CF; Hudson CN
    Gynecol Oncol; 1987 Oct; 28(2):137-50. PubMed ID: 3311922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study of amplifications of myc gene (c-myc and N-myc) in human ovarian cancer].
    Kataoka A; Yakushiji M; Kojiro M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):259-63. PubMed ID: 2332674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of metallothionein and nuclear size in discrimination of malignancy in mucinous ovarian tumors.
    Tan Y; Sinniah R; Bay BH; Singh G
    Int J Gynecol Pathol; 1999 Oct; 18(4):344-50. PubMed ID: 10542943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-myc oncogene expression in anal squamous neoplasia.
    Ogunbiyi OA; Scholefield JH; Rogers K; Sharp F; Smith JH; Polacarz SV
    J Clin Pathol; 1993 Jan; 46(1):23-7. PubMed ID: 7679417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors.
    Sugai M; Umezu H; Yamamoto T; Jiang S; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
    Pathol Int; 2008 Nov; 58(11):681-6. PubMed ID: 18844932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear morphometry and AgNOR quantification: computerized image analysis on ovarian mucinous tumor imprints.
    Versa-Ostojić D; Stanković T; Stemberger-Papić S; Vrdoljak-Mozetic D; Manestar M; Krasević M
    Anal Quant Cytol Histol; 2008 Jun; 30(3):160-8. PubMed ID: 18630841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.
    Mok SC; Bell DA; Knapp RC; Fishbaugh PM; Welch WR; Muto MG; Berkowitz RS; Tsao SW
    Cancer Res; 1993 Apr; 53(7):1489-92. PubMed ID: 8384077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-myc oncogene expression in ocular melanomas.
    Royds JA; Sharrard RM; Parsons MA; Lawry J; Rees R; Cottam D; Wagner B; Rennie IG
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(4):366-71. PubMed ID: 1505770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
    Evans MF; McDicken IW; Herrington CS
    J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.
    Sieben NL; Macropoulos P; Roemen GM; Kolkman-Uljee SM; Jan Fleuren G; Houmadi R; Diss T; Warren B; Al Adnani M; De Goeij AP; Krausz T; Flanagan AM
    J Pathol; 2004 Mar; 202(3):336-40. PubMed ID: 14991899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosomal analysis in malignant ovarian tumors.
    Sonwalker AA; Grover S
    Am J Obstet Gynecol; 1974 Apr; 118(7):961-5. PubMed ID: 4361960
    [No Abstract]   [Full Text] [Related]  

  • 35. Histological discrimination of malignancy in mucinous ovarian tumours.
    Blanco AA; Gibbs AC; Langley FA
    Histopathology; 1977 Nov; 1(6):431-43. PubMed ID: 210104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Overexpression of c-erbB-2 oncogene in primary ovarian cancers: incidence and prognostic significance in 243 patients].
    Meden H; Marx D; Rath W; Kuhn W; Hinney B; Schauer A
    Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):667-73. PubMed ID: 1360438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours.
    Hynninen P; Vaskivuo L; Saarnio J; Haapasalo H; Kivelä J; Pastoreková S; Pastorek J; Waheed A; Sly WS; Puistola U; Parkkila S
    Histopathology; 2006 Dec; 49(6):594-602. PubMed ID: 17163844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneous genetic alterations in ovarian mucinous tumors: application and usefulness of laser capture microdissection.
    Takeshima Y; Amatya VJ; Daimaru Y; Nakayori F; Nakano T; Inai K
    Hum Pathol; 2001 Nov; 32(11):1203-8. PubMed ID: 11727259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A huge ovarian mucinous cystadenoma in a 14-year-old premenarchal girl: review on ovarian mucinous tumor in premenarchal girls.
    Karaman A; Azili MN; Boduroğlu EC; Karaman I; Erdoğan D; Cavuşoğlu YH; Aslan MK; Cakmak O
    J Pediatr Adolesc Gynecol; 2008 Feb; 21(1):41-4. PubMed ID: 18312801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian mucinous cystadenoma of borderline malignancy in a premenarchal girl.
    Iwasaki M; Taira K; Kobayashi H; Saiga T
    J Pediatr Adolesc Gynecol; 2010 Jun; 23(3):e119-23. PubMed ID: 19896401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.